UK Statutory Instrument SI 2024/1319 United Kingdom

The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024

Status
In Force

What it defines

Regulations creating concrete business duties or carrying penalties, grouped as the instrument is structured. Titles link to the source text — blue means you’re leaving for legislation.gov.uk.

9 other provisions — procedural and definitional
s.art001 Citation, commencement, extent and application
s.art002 Interpretation
s.art003 Definition of “supply”, which includes an exclusion from the scope of this Order of supplies for the purposes of an authorised clinical trial
s.art004 Prohibition on the sale or supply of medicinal products consisting of or containing gonadotrophin-releasing hormone analogues
s.art005 Exception for all NHS prescriptions
s.art006 Exception for private prescriptions: patients aged 18 or over
s.art007 Exception for private prescriptions: patients aged under 18 – treatment for a purpose other than puberty suppression in respect of gender dysphoria etc.
s.art008 Exception for private prescriptions: patients aged under 18 – treatment for the purposes of puberty suppression in respect of gender dysphoria etc.
s.art009 Reviews

Duty extraction and severity labels are Guvnor’s analysis of the instrument, not the instrument itself. Always verify against the linked source text.